Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endocyte Inc (NASDAQ:ECYT)

2.30
Delayed Data
As of 4:00pm ET
 -0.01 / -0.43%
Today’s Change
1.98
Today|||52-Week Range
4.19
-9.80%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-18.0M5.5M-41.3M-43.9M
 
 
 
 
 
Depreciation674.7K857.1K886.7K919.8K
 
 
 
 
 
Total Other Cash Flow7.3M9.6M8.3M9.7M
 
 
 
 
 
Funds From Operations-10.1M16.0M-32.1M-33.3M
 
 
 
 
 
Funds From/For Other Operating Expenses41.0M58.2M128.1K1.4M
 
 
 
 
 
Net Cash Flow - Operating Activities-51.1M-42.2M-32.2M-34.7M
 
 
 
 
 
 
InvestingIncrease In Investments-125.0M-149.4M-86.3M-139.9M
 
 
 
 
 
Decrease In Investments195.1M82.3M88.1M190.8M
 
 
 
 
 
Capital Expenditures-827.8K-1.5M-341.6K-713.8K
 
 
 
 
 
Fixed Asset Disposal--10.0K0.000.00
 
 
Net Cash Flow Investing69.3M-68.6M1.5M50.1M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale644.9K103.5M684.3K492.9K
 
 
 
 
 
Common Preferred Redeemed0.00-3.8K-57.3K-164.5K
 
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing644.9K103.5M627.0K328.5K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-6.8K-38.8K-1.4K0.00
 
 
 
 
 
Net Change In Cash18.9M-7.3M-30.1M15.8M